GlaxoSmithKline (GSK) is a global pharmaceutical company with a diversified portfolio of biologics, small molecules and consumer healthcare products. In Oncology GSK’s pipeline is focused on immuno-oncology, cell therapy, cancer epigenetics and synthetic lethality. The company was formed in 2000 as a result of merger between GlaxoWellcome plc and SmithKline Beecham.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
